Skip to main navigation Skip to search Skip to main content

Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity

  • Sibren Haesen
  • , Manon Marie Jager
  • , Aline Brillouet
  • , Iris de Laat
  • , Lotte Vastmans
  • , Eline Verghote
  • , Anouk Delaet
  • , Sarah D'Haese
  • , Ibrahim Hamad
  • , Markus Kleinewietfeld
  • , Jeroen Mebis
  • , Wilfried Mullens
  • , Ivo Lambrichts
  • , Esther Wolfs
  • , Dorien Deluyker
  • , Virginie Bito*
  • *Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

The use of doxorubicin (DOX) chemotherapy is restricted due to dose-dependent cardiotoxicity. Pyridoxamine (PM) is a vitamin B6 derivative with favorable effects on diverse cardiovascular diseases, suggesting a cardioprotective effect on DOX-induced cardiotoxicity. The cardioprotective nature of PM was investigated in a rat model of DOX-induced cardiotoxicity. Six-week-old female Sprague Dawley rats were treated intravenously with 2 mg/kg DOX or saline (CTRL) weekly for eight weeks. Two other groups received PM via the drinking water next to DOX (DOX+PM) or saline (CTRL+PM). Echocardiography, strain analysis, and hemodynamic measurements were performed to evaluate cardiac function. Fibrotic remodeling, myocardial inflammation, oxidative stress, apoptosis, and ferroptosis were evaluated by various in vitro techniques. PM significantly attenuated DOX-induced left ventricular (LV) dilated cardiomyopathy and limited TGF-ß1-related LV fibrotic remodeling and macrophage-driven myocardial inflammation. PM protected against DOX-induced ferroptosis, as evidenced by restored DOX-induced disturbance of redox balance, improved cytosolic and mitochondrial iron regulation, and reduced mitochondrial damage at the gene level. In conclusion, PM attenuated the development of cardiac damage after DOX treatment by reducing myocardial fibrosis, inflammation, and mitochondrial damage and by restoring redox and iron regulation at the gene level, suggesting that PM may be a novel cardioprotective strategy for DOX-induced cardiomyopathy.
Original languageEnglish
Article number112
Number of pages18
JournalAntioxidants
Volume13
Issue number1
DOIs
Publication statusPublished - 17 Jan 2024

Keywords

  • anthracyclines
  • cardioprotection
  • cardiotoxicity
  • inflammation
  • mitochondria
  • preclinical study
  • pyridoxamine
  • redox biology

Fingerprint

Dive into the research topics of 'Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity'. Together they form a unique fingerprint.

Cite this